MDGL Quarterly Accounts Receivable
$30.46 M
+$23.56 M+341.56%
30 September 2024
Summary:
As of January 23, 2025, MDGL quarterly accounts receivable is $30.46 million, with the most recent change of +$23.56 million (+341.56%) on September 30, 2024. Over the past year, it has increased by +$23.56 million (+341.56%). MDGL quarterly accounts receivable is now at all-time high.MDGL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +341.6% |
| 3 y3 years | - | +341.6% |
| 5 y5 years | - | +341.6% |
MDGL Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +341.6% | ||
| 5 y | 5-year | at high | +341.6% | ||
| alltime | all time | at high | +341.6% |
Madrigal Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $30.46 M(+341.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $6.90 M |
FAQ
- What is Madrigal Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Madrigal Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of MDGL is $30.46 M
What is the all time high quarterly accounts receivable for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly accounts receivable is $30.46 M
What is Madrigal Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, MDGL quarterly accounts receivable has changed by +$23.56 M (+341.56%)